FY2025 · period end Dec '25 · from the 10-K filed Feb 4, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.63B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Figures a later SEC filing revised by more than 0.5% from what was originally reported. Each diff compares the same XBRL tag across two filings, so you can open both and check it yourself.
Increase (Decrease) in Accounts Payable
FY 2023
Revised down 669.2% — reported in a 10-K.
As first reported
-$13MAs it stands now
-$100MIncrease (Decrease) in Accounts Payable
Q2 2024
Revised down 136.6% — reported in a 10-Q.
As first reported
-$41MAs it stands now
-$97MIncrease (Decrease) in Accounts Payable
Q1 2024
Revised down 61.7% — reported in a 10-Q.
As first reported
$81MAs it stands now
$31MIncrease (Decrease) in Accounts Payable
FY 2024
Revised down 52.4% — reported in a 10-K.
As first reported
$126MAs it stands now
$60MRestructuring Charges
FY 2023
Revised down 31.5% — reported in a 10-K.
As first reported
$54MAs it stands now
$37MDeferred Tax Assets, Net of Valuation Allowance
As of Dec 31, 2023
Revised up 2.3% — reported in a 10-K.
As first reported
$4.5BAs it stands now
$4.6BRestatements are detected by comparing every vintage of a fact across all of GE HealthCare Technologies Inc.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows GEHC's most significant revisions, and a figure absent from it has not been certified as unrevised.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001932393-26-000034 | May 7, 2026 | May 11, 2026 | May 11, 2026 20:51 UTC | EDGAR |
| 8-K | 0001932393-26-000030 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 10:25 UTC | EDGAR |
| 10-Q | 0001932393-26-000031 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 10:26 UTC | EDGAR |
| 8-K | 0001932393-26-000013 | Mar 13, 2026 | Mar 17, 2026 | Mar 17, 2026 13:14 UTC | EDGAR |
| 8-K | 0001932393-26-000010 | Feb 26, 2026 | Feb 27, 2026 | Feb 27, 2026 21:15 UTC | EDGAR |
| 8-K | 0001932393-26-000006 | Feb 4, 2026 | Feb 4, 2026 | Feb 4, 2026 11:25 UTC | EDGAR |
| 10-K | 0001932393-26-000007 | Dec 31, 2025 | Feb 4, 2026 | Feb 4, 2026 11:28 UTC | EDGAR |
| 8-K | 0001193125-25-319383 | Dec 12, 2025 | Dec 15, 2025 | Dec 15, 2025 22:02 UTC | EDGAR |
Direct links to SEC EDGAR. GEHC has additional filings available on the SEC site.
Who is buying and selling GE HealthCare Technologies Inc. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on GEHC yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on GEHC and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $19.55B |
| $18.34B |
| $17.59B |
| Gross Profit | $8.25B | $8.21B | $7.92B | $7.18B | $7.17B |
|---|
| Operating Income | $2.76B | $2.63B | $2.44B | $2.52B | $2.79B |
|---|
| Net Income | $2.08B | $1.99B | $1.57B | $1.92B | $2.25B |
|---|
| EPS (Diluted) | $4.55 | $4.34 | $3.03 | $4.22 | $4.95 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $36.91B | $33.09B | $32.45B | $27.54B | — |
| Total Liabilities | $26.31B | $24.44B | $25.14B | $17.95B | — |
| Stockholders' Equity | $10.39B | $8.46B | $7.14B | $9.36B | $16.68B |
| Cash & Equivalents | $4.49B | $2.89B | $2.51B | $1.45B | $0.56B |
| Total Debt | $10.02B | $9.04B | $9.45B | $8.30B | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | — | — | — | — | — |
| Capital Expenditures | — | — | — | — | — |
| Free Cash Flow | — | — | — | — | — |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 40.0% | 41.7% | 40.5% | 39.1% | 40.8% |
| Operating Margin | 0.1% | 0.1% | 0.1% | 0.1% | 15.9% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.1% | 12.8% |
| Return on Equity | 22.1% | 25.5% | 19.0% | 14.7% | 13.5% |
| Return on Assets | 6.0% | 6.1% | 5.2% | 7.0% | — |
| Debt / Equity | 0.96× | 1.07× | 1.32× | 0.89× | — |
